Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax

por Alexandra G. A. Stewart, Peter A. Zimmerman, James S. McCarthy, James S. McCarthy
Publicado 2021

Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial.

por Nicolas Senn, Patricia Rarau, Danielle I Stanisic, Leanne Robinson, Céline Barnadas, Doris Manong, Mary Salib, Jonah Iga, Nandao Tarongka, Serej Ley, Anna Rosanas-Urgell, John J Aponte, Peter A Zimmerman, James G Beeson, Louis Schofield, Peter Siba, Stephen J Rogerson, John C Reeder, Ivo Mueller
Publicado 2012

Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control study.

por Anna Rosanas-Urgell, Enmoore Lin, Laurens Manning, Patricia Rarau, Moses Laman, Nicolas Senn, Brian T Grimberg, Livingstone Tavul, Danielle I Stanisic, Leanne J Robinson, John J Aponte, Elijah Dabod, John C Reeder, Peter Siba, Peter A Zimmerman, Timothy M E Davis, Christopher L King, Pascal Michon, Ivo Mueller
Publicado 2012